Table 1 In-silico screening of potencial E-FABP inhibitors

EI-01

C22H29N3O7

447.48816

benzyl 2-(((R-methoxy-2-oxoethyl)amino)-4-methyl-1-oxopentan-2-yl)carbamoyl)-5-oxopyrrolidine-1-carboxylate

EI-02

C20H18N4O4

378.38732

1-phenyl-6-(3,4,5-trimethoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4(5H)-one

EI-03

C22H20N2O5

392.4112

2-(4-acetylphenoxy)-9,10-dimethoxy-6,7-dihydro[6,1-a]isoquinolin-4-one

EI-04

C20H14N4O

326.35736

2-(furan-2-yl)-1-(m-tolyl)-1H-imi-dazo[4,5-b]quinoxaline

EI-06

C20H19NO5

353.37456

2-((−hydroxy-4-oxo-2-phenyl-4H-chromen-7-yl)oxy)-N-propylacetamide